Zimmer Biomet stock trades at USD 91.57, up 2.10 percent in New York trading
Published on 09/25/2026 at 18:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Zimmer Biomet stock was last at USD 91.57 in New York trading on September 25, 2026, up 2.10 percent from the prior session's USD 89.69. The gain exceeded the 0.46 percent advance in SPY at 12:52 p.m. ET by 1.64 percentage points. The shares were still trading at USD 91.57 at 12:51 p.m. ET, before the regular US session ended.
The session on September 25, 2026 in figures
Zimmer Biomet Holdings, Inc. (ISIN US98956P1021) opened at USD 89.53 on the New York Stock Exchange. The session range stood at USD 89.24 to USD 91.84 at 12:51 p.m. ET. The latest level was USD 15.31 below the 52-week high of USD 106.88 and USD 12.45 above the 52-week low of USD 79.12. Trading volume reached 474,121 shares, compared with an average volume of 2,230,484 shares.
The stock rose USD 1.88 from the prior session's USD 89.69 reference level. The available intraday figures showed the shares moving from the opening level toward the session high. The latest level remained USD 0.27 below the session high and USD 2.33 above the session low. The 12:51 p.m. ET quote provided the latest dated level for the New York session.
Analyst estimates support the September 25, 2026 move
As Zacks reported on September 25, 2026, Zimmer Biomet carried a No. 3, or Hold, Zacks Rank. Zacks said 10 analysts had revised their fiscal 2026 earnings estimates higher during the previous 60 days. The consensus estimate increased by USD 0.06 to USD 8.54 per share, while the average earnings surprise was reported at 4.5 percent.
The estimate revision data supplied the day's dated company-specific market context. The medical device group showed mixed trading at 12:52 p.m. ET. Stryker gained 2.06 percent, Edwards Lifesciences rose 0.90 percent and Boston Scientific fell 2.12 percent. Zimmer Biomet's 2.10 percent gain exceeded all three peer moves except Stryker's percentage advance.
Medical device peers and US market levels on September 25, 2026
The SPY exchange-traded fund, used as an S&P 500 market proxy, stood at USD 770.73, up 0.46 percent at 12:52 p.m. ET. The QQQ Nasdaq 100 proxy was at USD 744.45, up 0.45 percent at the same time. Zimmer Biomet traded 1.64 percentage points above SPY and 1.65 percentage points above QQQ on the percentage measure. The company's volume was 21.3 percent of its stated average at that time.
Dividend record date on September 30, 2026
MarketBeat reported on September 24, 2026, that shareholders of record on September 30, 2026, would receive Zimmer Biomet's quarterly dividend of USD 0.24 per share. The record date falls within the next five trading days and provides the next dated shareholder event. The event adds a cash distribution consideration to the upcoming trading calendar.
